An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...

A new drug for treatment-resistant depression will be listed on the Pharmaceutical Benefits Scheme this week, making it more ...

A new nasal spray, that’s chemically similar to Ketamine, is being added to the Pharmaceutical Benefits Scheme, for adults ...

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...

A novel approach to treating depression derived from a popular club drug offers hope to tens of thousands of Australians ...

A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making it much cheaper for the estimated 30,000 Australians with treatment ...